New York, Feb. 14, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Hemostat Market size is forecasted to exceed USD 5.7 Billion by 2033, with a promising CAGR of 6.4% from 2024 to 2033.

Pakistan has patented and developed its first-ever lifesaving hemostat dressing, capable of stopping bleeding within seconds and potentially saving tens of thousands of lives each year. A team at the ...

Baxter Healthcare is pleased to share the growing success of the room temperature storage configuration of Hemopatch Sealing Hemostat, launched earlier, this Summer, across Australia and New Zealand.

Trusted for Over a Decade. For over a decade, Hemopatch sealing hemostat has been a trusted companion in surgeries worldwide, providing critical support and precision under pressure, while evolving ...

Surgicel Powder Absorbable Hemostat is a powdered adjunctive hemostat used to control disruptive bleeding. Ethicon announced the launch of Surgicel Powder Absorbable Hemostat (oxidized regenerated ...

Innovation is a direct result of collaborative efforts with surgeons, helping to ensure that customer needs are met and promoting enhanced patient care "For over a decade, Hemopatch Sealing Hemostat ...

Etamsylate (Hemostat) is a haemostatic agent, prescribed for the management of blood loss in menorrhagia, and after surgery.It reduces bleeding from very small blood vessels (capillaries). The ...

Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance.

Hemopatch Sealing Hemostat with room temperature storage now available in Europe New product evolution enables direct accessibility in the operating room Innovation is a direct result of collaborative ...